Loading insider details...
Latest Form 4 (Aug 20, 2026): Sale of 229,338 PROK shares, $314.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 20, 2026 | PROKIDNEY CORP. (PROK) | Sale | 229,338 | $314.5K |
| Aug 6, 2026 | PROKIDNEY CORP. (PROK) | Conversion | 81,929 | n/a |
| Jun 11, 2026 | KalVista Pharmaceuticals, Inc. (KALV) | Disposition to Issuer | 14,000 | n/a |
| May 29, 2026 | PROKIDNEY CORP. (PROK) | Grant/Award | 135,000 | n/a |
| Nov 14, 2025 | PROKIDNEY CORP. (PROK) | Sale | 227,431 | $619.4K |
| Oct 2, 2025 | KalVista Pharmaceuticals, Inc. (KALV) | Grant/Award | 30,000 | n/a |
| Jun 2, 2025 | PROKIDNEY CORP. (PROK) | Grant/Award | 125,862 | n/a |
| Feb 6, 2025 | PROKIDNEY CORP. (PROK) | Conversion | 81,928 | n/a |
| Oct 4, 2024 | KalVista Pharmaceuticals, Inc. (KALV) | Grant/Award | 10,000 | n/a |
| Jun 3, 2024 | PROKIDNEY CORP. (PROK) | Grant/Award | 62,558 | n/a |